Skip to content
Medications

GLP-1 Pills: FDA-Approved Oral Weight Loss Options

6 min readLast updated By Jeremy H., GLP-1 Nutrition Researcher
GLP-1 Pills: FDA-Approved Oral Weight Loss Options
§

This article may contain affiliate links. If you click and make a purchase, we may earn a commission at no extra cost to you. Full disclosure policy

Not everyone wants to inject medication. Good news: oral GLP-1 options exist and more are coming.

Approval Status at a Glance

Pill Approved for FDA approval date NDA
Rybelsus (oral semaglutide) Type 2 diabetes September 20, 2019 213051
Wegovy pill (oral semaglutide 25 mg) Weight management December 22, 2025 218316
Foundayo (orforglipron) Weight management April 1, 2026 220934

Status checked November 2026. The Wegovy pill also received EU approval on July 15, 2026. No other oral GLP-1 is FDA-approved for weight management as of this date — anything else marketed as a "GLP-1 pill" is either a supplement (not a drug) or a compounded product (not FDA-approved).

What Oral GLP-1 Options Exist?

Foundayo (Orforglipron) — Newest Option

The newest FDA-approved GLP-1 pill, approved April 1, 2026 (NDA 220934). Made by Eli Lilly.

  • Daily pill with no food or water restrictions — take any time, with or without food
  • Non-peptide GLP-1 receptor agonist (different from semaglutide)
  • Dosing: starts at 3 mg, titrates up to 17.2 mg
  • Weight loss: ~11% average over 72 weeks at the highest dose
  • FDA-approved for weight management

This is the biggest advance in oral GLP-1 convenience. Foundayo removes the strict food-timing rules that made Rybelsus hard for many people. See our Foundayo guide for the full breakdown.

Rybelsus (Oral Semaglutide)

The first FDA-approved oral GLP-1, approved September 20, 2019 (NDA 213051). It's semaglutide in pill form, taken daily.

  • Currently approved for type 2 diabetes
  • Must take on empty stomach with no more than 4 oz of water
  • Must wait 30 minutes before eating or drinking
  • Dosing: 3 mg, 7 mg, 14 mg

Wegovy Pill (Oral Semaglutide for Weight Loss)

A once-daily oral semaglutide pill, FDA-approved for weight management on December 22, 2025 (NDA 218316) and available since January 2026. It also received EU approval on July 15, 2026.

  • Same active drug as Rybelsus, but a more bioavailable formulation with its own dosing ladder
  • Same food restrictions as Rybelsus
  • Titrates from 1.5 mg up to the highest approved dose, 25 mg (a 50 mg dose was studied in trials but is not FDA-approved)
  • In the OASIS 4 trial, patients on the 25 mg dose lost an average of 13.6% of body weight over 64 weeks, versus 2.2% on placebo
  • Gives patients who hate needles a real alternative

How Oral GLP-1 Works

Like injections, oral GLP-1 pills:

  • Mimic the GLP-1 hormone
  • Reduce appetite
  • Slow digestion
  • Help control blood sugar

The catch with oral semaglutide (Rybelsus and Wegovy pill): they must be taken on an empty stomach with a small amount of water, and you need to wait before eating. Foundayo does not have this restriction.

GLP-1 medication news, in plain English

New approvals, pens, pills, prices and label changes across GLP-1 medications. One free email a week.

Pill vs Injection

Feature Foundayo (pill) Rybelsus / Wegovy Pill GLP-1 Injection
How often Daily Daily Weekly
Needles No No Yes
Food rules None Empty stomach, wait 30 min None
Side effects Similar GI symptoms Similar GI symptoms Similar GI symptoms
Weight loss ~11% Rybelsus: less data for weight; Wegovy Pill: ~13.6% average Wegovy ~15%, Zepbound ~20%
Cost Similar range Similar range Similar range

Which Pill, for Whom?

  • People afraid of needles
  • People who prefer daily routines
  • Anyone who has trouble with injections
  • People who travel frequently and can't easily keep injections cold
If you… The pill that fits Why
Want the simplest daily routine, no timing rules Foundayo No food or water restrictions — take any time, with or without food. See our Foundayo guide.
Want the most weight loss from a pill and can follow a morning routine Wegovy pill Strongest oral weight loss in clinical trials: 13.6% average in OASIS 4 (64 weeks), versus 2.2% on placebo. The tradeoff is strict timing — empty stomach, small sip of water, wait 30 minutes before eating or drinking. See our Wegovy pill vs injection comparison.
Have type 2 diabetes and prefer a pill Rybelsus The only oral GLP-1 approved for type 2 diabetes. Same food rules as the Wegovy pill. Not approved for weight management on its own.
Cannot follow a 30-minute empty-stomach routine Foundayo, or an injection The food rules are the reason many people stop Rybelsus. Foundayo removes them; weekly injections never had them.

Foundayo specifically may be best if you:

  • Could not handle the Rybelsus food restrictions
  • Want the simplest daily pill routine possible
  • Prefer no timing rules around meals

Products for daily pill users:

What to Ask Your Doctor

  1. Is an oral GLP-1 right for me?
  2. Which oral option is best — Foundayo or oral semaglutide?
  3. How does it compare to injections for weight loss?
  4. What side effects should I expect?
  5. What will it cost with my insurance?
  6. How do I take it for best results?

The Bottom Line

Oral GLP-1 pills give you the same benefits as injections without the needle. Foundayo goes further — no food rules, no water timing, just a daily pill. Talk to your doctor about whether a pill is right for you.

Talk to your doctor about the best treatment for you. This article is for information only and is not medical advice. Last updated: November 16, 2026.

Related Reading

GLP-1 medication news, in plain English

New approvals, pens, pills, prices and label changes across GLP-1 medications. One free email a week.

We respect your privacy. Unsubscribe anytime.

Next up

A few related reads to keep your momentum.

Related articles

Written by
J
Jeremy H.
GLP-1 Nutrition Researcher

Nutrition researcher and founder of The GLPSpot. Jeremy built this site after watching friends and family struggle with the nutritional challenges of reduced appetite on GLP-1 medications — loss of muscle mass, dehydration, and nutrient deficiencies.

Published:
Medical Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment.